Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Subjects with obesity frequently have elevated serum vasopressin levels, noted by measuring the stable analog, copeptin. Vasopressin acts primarily to reabsorb water via urinary concentration. However, fat is also a source of metabolic water, raising the possibility that vasopressin might have a role in fat accumulation. Fructose has also been reported to stimulate vasopressin. Here, we tested the hypothesis that fructose-induced metabolic syndrome is mediated by vasopressin. Orally administered fructose, glucose, or high-fructose corn syrup increased vasopressin (copeptin) concentrations and was mediated by fructokinase, an enzyme specific for fructose metabolism. Suppressing vasopressin with hydration both prevented and ameliorated fructose-induced metabolic syndrome. The vasopressin effects were mediated by the vasopressin 1b receptor (V1bR), as V1bR-KO mice were completely protected, whereas V1a-KO mice paradoxically showed worse metabolic syndrome. The mechanism is likely mediated in part by de novo expression of V1bR in the liver that amplifies fructokinase expression in response to fructose. Thus, our studies document a role for vasopressin in water conservation via the accumulation of fat as a source of metabolic water. Clinically, they also suggest that increased water intake may be a beneficial way to both prevent or treat metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., Willett, W. C., & Hu, F. B. (2010) · Diabetes Care · doi:10.2337/dc10-1079 · Cited by 2,116
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Added sugar intake and cardiovascular diseases mortality among US adults
Yang, Q., Zhang, Z., Gregg, E. W., Flanders, W. D., Merritt, R., & Hu, F. B. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13563 · Cited by 947 · cited 2×
“Sugar intake, especially from soft drinks, is strongly associated with the development of metabolic syndrome (1, 2) and may also increase cardiovascular mortality (3, 4).”
InfluentialMalik, V. S., Li, Y., Pan, A., De Koning, L., Schernhammer, E., Willett, W. C., & Hu, F. B. (2019) · Circulation · doi:10.1161/circulationaha.118.037401 · Cited by 421
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299 · cited 2×
“Elevated copeptin can also increase the risk of obesity and diabetes (17, 21).”
Softic, S., Meyer, J. G., Wang, G.-X., Gupta, M. K., Batista, T. M., Lauritzen, H. P. M. M., Fujisaka, S., Serra, D., Herrero, L., Willoughby, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.003 · Cited by 227 · cited 1×
“Experimental studies suggest that the fructose component in sugar is the primary culprit (8) and that fructose induces its effects by shifting energy production to energy storage (9–12).”
Stookey, J. D., Constant, F., Popkin, B. M., & Gardner, C. D. (2008) · Obesity · doi:10.1038/oby.2008.409 · Cited by 175
Saleem, U., Khaleghi, M., Morgenthaler, N. G., Bergmann, A., Struck, J., Mosley, T. H., & Kullo, I. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2278 · Cited by 161
Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., Bremer, A. A., Berglund, L., McGahan, J. P., Havel, P. J., et al. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.159 · Cited by 132 · cited 1×
“Experimental studies suggest that the fructose component in sugar is the primary culprit (8) and that fructose induces its effects by shifting energy production to energy storage (9–12).”
Taveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D. G., Arthus, M.-F., Magnan, C., Philippe, E., Paradis, V., Foufelle, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3496-9 · Cited by 86 · cited 2×
“In this regard, Taveau et al. have also reported that water loading could reduce fatty liver in the obese Zucker rat (22).”
Cited by
The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases
Malik, V. S., & Hu, F. B. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00627-6 · Cited by 854
Molecular aspects of fructose metabolism and metabolic disease
Herman, M. A., & Birnbaum, M. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.010 · Cited by 290
The role of ChREBP in carbohydrate sensing and NAFLD development
Régnier, M., Carbinatti, T., Parlati, L., Benhamed, F., & Postic, C. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00809-4 · Cited by 101
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets
Volek, J. S., Phinney, S. D., Krauss, R. M., Johnson, R. J., Saslow, L. R., Gower, B., Yancy, W. S., King, J. C., Hecht, F. M., Teicholz, N., et al. (2021) · Nutrients · doi:10.3390/nu13103299 · Cited by 57
“These negative effects of high sodium intake can be reversed by hydration [171,172].”
BackgroundSelf-citation
Metadata
- Authors
- Andres-Hernando, A., Jensen, T. J., Kuwabara, M., Orlicky, D. J., Cicerchi, C., Li, N., Roncal-Jimenez, C. A., Garcia, G. E., Ishimoto, T., Maclean, P. S., Bjornstad, P., Sanchez-Lozada, L. G., Kanbay, M., Nakagawa, T., Johnson, R. J., & Lanaspa, M. A.
- Venue
- JCI Insight
- Published
- 2021-01-11
- Volume
- 6
- Issue
- 1
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W3113364790
- Cited by
- 56
- References
- 10
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor. https://app.cochat.ai/papers/10.1172/jci.insight.140848
- The paper
- Andres-Hernando, A., Jensen, T. J., Kuwabara, M., Orlicky, D. J., Cicerchi, C., Li, N., Roncal-Jimenez, C. A., Garcia, G. E., Ishimoto, T., Maclean, P. S., Bjornstad, P., Sanchez-Lozada, L. G., Kanbay, M., Nakagawa, T., Johnson, R. J., & Lanaspa, M. A. (2021). Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor. JCI Insight. https://doi.org/10.1172/jci.insight.140848
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.